Brookline, MA, United States of America

Dipanjan Chowdhury

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: Dana-Farber-Cancer Institute Inc., Medical University of Lodz, The Brigham and Women's Hospital, Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dipanjan Chowdhury. Retrieved from https://idiyas.com/inventor/dipanjan-chowdhury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Chestnut Hill, MA (US) (2016 - 2017)
  • Brookline, MA (US) (2020 - 2022)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Dipanjan Chowdhury

Introduction

Dipanjan Chowdhury, a prominent inventor based in Brookline, Massachusetts, has made significant strides in the field of medical innovation, particularly focusing on cancer diagnostics and treatment. With a total of five patents to his name, his work emphasizes the utility of microRNA biomarkers in identifying and treating ovarian cancer, showcasing the intersection of technology and healthcare.

Latest Patents

One of Dipanjan Chowdhury's latest patents is centered on "Circulating microRNA signatures for ovarian cancer." This invention comprises methods and kits designed to detect specific microRNA biomarkers in the blood samples of female patients. These biomarkers are directly associated with ovarian cancer, and his work includes methods for both screening subjects for these biomarkers and providing treatment options for those diagnosed with the condition. His repeated focus on these methods demonstrates a robust commitment to enhancing cancer diagnostics and patient care.

Career Highlights

Throughout his career, Dipanjan has held influential positions at esteemed institutions such as the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. His role in these organizations has allowed him to propel research initiatives and contribute to groundbreaking advancements in cancer treatment and technology. His inventions have the potential to change the way ovarian cancer is diagnosed and treated, highlighting his dedication to improving patient outcomes.

Collaborations

Collaboration has been a crucial aspect of Dipanjan Chowdhury's career. He has worked alongside notable colleagues, including Kevin M. Elias and Wojciech Fendler. These partnerships not only enhance the innovation process but also contribute to a diverse approach to problem-solving in the realm of cancer research and treatment.

Conclusion

Dipanjan Chowdhury stands as a notable figure in the landscape of medical innovation. His contributions, particularly in the realm of ovarian cancer diagnostics and treatment, illustrate the impact of dedicated research and invention on healthcare. As he continues to develop methods that could revolutionize patient care, his work serves as an inspiration for future inventors and researchers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…